NovaBridge Biosciences American Depositary Shares (NBP) is a publicly traded the market company. As of May 21, 2026, NBP trades at $1.80 with a market cap of $197.76M and a P/E ratio of 0.00. NBP moved +5.36% today. Year to date, NBP is -59.73%; over the trailing twelve months it is flat. Its 52-week range spans $1.67 to $5.19. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces NBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NovaBridge Biosciences American Depositary Shares (NBP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NBP moved +5.36% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.80 |
| Market Cap | $197.76M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.19 |
| 52-Week Low | $1.67 |
| Volume | 1.09M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover NBP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.